125 related articles for article (PubMed ID: 11566166)
1. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Nacmias B; Tedde A; Forleo P; Piacentini S; Guarnieri BM; Bartoli A; Ortenzi L; Petruzzi C; Serio A; Marcon G; Sorbi S
Biol Psychiatry; 2001 Sep; 50(6):472-5. PubMed ID: 11566166
[TBL] [Abstract][Full Text] [Related]
2. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease.
Rocchi A; Micheli D; Ceravolo R; Manca ML; Tognoni G; Siciliano G; Murri L
Genet Test; 2003; 7(4):309-14. PubMed ID: 15000807
[TBL] [Abstract][Full Text] [Related]
3. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.
Quaranta D; Bizzarro A; Marra C; Vita MG; Seripa D; Pilotto A; Sebastiani V; Mecocci P; Masullo C
J Alzheimers Dis; 2009; 16(1):173-80. PubMed ID: 19158433
[TBL] [Abstract][Full Text] [Related]
4. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.
Holmes C; Arranz MJ; Powell JF; Collier DA; Lovestone S
Hum Mol Genet; 1998 Sep; 7(9):1507-9. PubMed ID: 9700207
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Craig D; Donnelly C; Hart D; Carson R; Passmore P
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):126-8. PubMed ID: 16967466
[TBL] [Abstract][Full Text] [Related]
7. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
8. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
10. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.
Craig D; Hart DJ; McCool K; McIlroy SP; Passmore AP
Ann Neurol; 2004 Jul; 56(1):121-4. PubMed ID: 15236409
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
[TBL] [Abstract][Full Text] [Related]
12. Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease.
Orlacchio A; Kawarai T; Paciotti E; Stefani A; Orlacchio A; Sorbi S; St George-Hyslop PH; Bernardi G
Neurosci Lett; 2002 May; 325(1):13-6. PubMed ID: 12023056
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
14. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study.
Angelucci F; Bernardini S; Gravina P; Bellincampi L; Trequattrini A; Di Iulio F; Vanni D; Federici G; Caltagirone C; Bossù P; Spalletta G
J Alzheimers Dis; 2009; 17(1):203-11. PubMed ID: 19494443
[TBL] [Abstract][Full Text] [Related]
15. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.
Assal F; Alarcón M; Solomon EC; Masterman D; Geschwind DH; Cummings JL
Arch Neurol; 2004 Aug; 61(8):1249-53. PubMed ID: 15313842
[TBL] [Abstract][Full Text] [Related]
16. Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
Kim J; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2017; 14(8):834-840. PubMed ID: 28219318
[TBL] [Abstract][Full Text] [Related]
17. The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.
Tang L; Wang Y; Chen Y; Chen L; Zheng S; Bao M; Xiang J; Luo H; Li J; Li Y
Biomed Res Int; 2017; 2017():5320135. PubMed ID: 29349076
[TBL] [Abstract][Full Text] [Related]
18. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL
J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
[TBL] [Abstract][Full Text] [Related]
19. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.
Pritchard AL; Harris J; Pritchard CW; Coates J; Haque S; Holder R; Bentham P; Lendon CL
Neurobiol Aging; 2008 Mar; 29(3):341-7. PubMed ID: 17098333
[TBL] [Abstract][Full Text] [Related]
20. The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease.
Sweet RA; Pollock BG; Sukonick DL; Mulsant BH; Rosen J; Klunk WE; Kastango KB; DeKosky ST; Ferrell RE
Int Psychogeriatr; 2001 Dec; 13(4):401-9. PubMed ID: 12003247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
